Antiparasitic Compounds from Cupania Cinerea with Activities Against Plasmodium Falciparum and Trypanosoma Brucei Rhodesiense
Overview
Authors
Affiliations
In a survey of plants from Ecuador with antiprotozoal activity, Cupania cinerea was found to show significant in vitro activity against the Plasmodium falciparum K1 strain and Trypanosoma brucei rhodesiense. Subsequently, activity-guided isolation of the n-hexane and dichloromethane extracts from the bark of C. cinerea afforded two diterpene glycosides (1 and 2), named cupacinoside and 6'-de-O-acetylcupacinoside, and a lactonized triterpene bearing an oxepin moiety named cupacinoxepin (3), together with the known compounds scopoletin (4), caryophyllene oxide (5), two bisabolane sesquiterpenes (6 and 7), lichexanthone (8), gustastatin (9), lupenone (10), betulone (11), 17β,21β-epoxyhopan-3-one (12), taraxerol (13), and taraxerone (14). For compound 3, X-ray crystallography was employed to elucidate the relative configuration. For cupacinosides (1) and (2) and cupacinoxepin (3), in vitro activities against the P. falciparum K1 strain (IC(50)1, 1.3; 2, 1.8; and 3, 8.7 μM) and T. b. rhodesiense (IC(50)1, 4.5; 2, 15.8; and 3, 71.6 μM) were found. Cytotoxicity toward L-6 cells is discussed for all the compounds isolated.
Discovery of fungal onoceroid triterpenoids through domainless enzyme-targeted global genome mining.
Tang J, Matsuda Y Nat Commun. 2024; 15(1):4312.
PMID: 38773118 PMC: 11109268. DOI: 10.1038/s41467-024-48771-7.
The Biosynthesis and Medicinal Properties of Taraxerol.
Mus A, Wah Goh L, Marbawi H, Gansau J Biomedicines. 2022; 10(4).
PMID: 35453556 PMC: 9025716. DOI: 10.3390/biomedicines10040807.
Darme P, Escotte-Binet S, Cordonnier J, Remy S, Hubert J, Sayagh C Parasite. 2022; 29:7.
PMID: 35142606 PMC: 8830292. DOI: 10.1051/parasite/2022008.
Kim D, Kim K Int J Mol Sci. 2021; 22(22).
PMID: 34830415 PMC: 8624521. DOI: 10.3390/ijms222212523.
Targeted Isolation of Anti-Trypanosomal Naphthofuran-Quinone Compounds from the Mangrove Plant .
Mazlan N, Clements C, Edrada-Ebel R Mar Drugs. 2020; 18(12).
PMID: 33371387 PMC: 7767399. DOI: 10.3390/md18120661.